Glenview Capital Management logo

Glenview Capital Management

North America, New York, United States, New York

Description

Glenview Capital Management is a hedge fund founded in 2000 with approximately $9.2 billion of capital under management.

Investor Profile

Glenview Capital Management has made 9 investments, with 1 in the past 12 months and 44% as lead.

Stage Focus

  • Post Ipo Equity (33%)
  • Series D (22%)
  • Series B (11%)
  • Series C (11%)
  • Series A (11%)
  • Series E (11%)

Country Focus

  • United States (78%)
  • United Kingdom (22%)

Industry Focus

  • Health Care
  • Medical
  • Medical Device
  • Clinical Trials
  • Manufacturing
  • Personal Health
  • Energy
  • Renewable Energy
  • Solar
  • Wind Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Glenview Capital Management frequently co-invest with?

OM
North America, Massachusetts, United States, Boston
Co-Investments: 1
General Electric
North America, Massachusetts, United States, Boston
Co-Investments: 1
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 2
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Eldridge Industries
North America, Connecticut, United States, Greenwich
Co-Investments: 4
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 3
AC
North America, Illinois, United States, Chicago
Co-Investments: 1
Affinity Asset Advisors
North America, New York, United States, New York
Co-Investments: 1
Capricorn Investment Group
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does Glenview Capital Management often collaborate with?

CS
North America, California, United States, Truckee
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Glenview Capital Management?

Quanta

Alcester, Warwickshire, United Kingdom

Quanta develops an advanced haemodialysis systems for use in the home and clinic.

Clinical TrialsHealth CareManufacturingMedicalMedical Device
Series ENov 18, 2024
Amount Raised: $60,000,000
Detect

Guilford, Connecticut, United States

Detect has developed a consumer-grade molecular diagnostics platform

Health CareMedicalPersonal Health
Series CNov 15, 2022
Limber

Washington, District of Columbia, United States

Limber is a digital health solution designed for employers, health plans, and providers.

FitnessHealth CareHospitalWellness
Series AOct 20, 2022
Amount Raised: $11,000,000
Quanta

Alcester, Warwickshire, United Kingdom

Quanta develops an advanced haemodialysis systems for use in the home and clinic.

Clinical TrialsHealth CareManufacturingMedicalMedical Device
Series DJun 23, 2021
Amount Raised: $245,000,000
Quantum SI

Guilford, Connecticut, United States

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

BiotechnologyHealth DiagnosticsLife Science
Post Ipo EquityJun 11, 2021
Amount Raised: $425,000,000
Tesseract Health

Guilford, Connecticut, United States

Tesseract Health provides devices for disease monitoring and prevention.

Health Care
Series BApr 20, 2021
Amount Raised: $80,000,000
Butterfly Network

Burlington, Massachusetts, United States

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

ElectronicsHealth CareMedical DevicePersonal Health
Post Ipo EquityFeb 16, 2021
Amount Raised: $175,000,000
SunEdison

Missouri City, Missouri, United States

SunEdison is the largest global renewable energy development company.

EnergyRenewable EnergySolarWind Energy
Post Ipo EquityJun 16, 2015
Amount Raised: $402,500,000
Calypso Medical

Seattle, Washington, United States

Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.

Health CareMedicalMedical Device
Series DJan 8, 2007
Amount Raised: $42,200,000